INSIGHTS ON CLINICAL TRIAL DESIGN
-
![clinical-trials-tech-GettyImages-1867575053]( "Reserving Data Integrity With Retrospective Manual Entry")
Reserving Data Integrity With Retrospective Manual EntryA look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
![Boost Feasibility webinar]( "Precision Feasibility And RWD Can Boost Participant Recruitment")
Precision Feasibility And RWD Can Boost Participant RecruitmentDiscover how integrating independent, holistic data with precision feasibility strategies can transform site enablement and patient recruitment to unlock new levels of trial success.
-
![20 20 onsite]( "High Density, Low Availability: Rethinking Ophthalmic Trial Readiness")
High Density, Low Availability: Rethinking Ophthalmic Trial ReadinessThe adoption of mobile ophthalmic solutions and collaboration with specialized vendors is recommended to ensure trial consistency and reach underserved regions.
-
![GettyImages-521848481 clinical trial, patient, diversity]( "Insights From The EACT Clinical Trials Site Personnel Webinar")
Insights From The EACT Clinical Trials Site Personnel WebinarCollaboration among clinical research stakeholders is breaking financial barriers to support equitable trial access.
-
Protocol Design Choices That Trigger IRB And Regulatory Requirements8/20/2026
Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.
-
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers6/25/2026
Psychedelic compounds show real promise for PTSD, but proving it requires solving unblinding, bias, and safety gaps in trial design.
-
Decentralized Clinical Trials: FDA Guidance Analyzed2/11/2025
Explore the evolution of the FDA decentralized clinical trial (DCT) guidance, highlighting key updates on responsibilities, data variability, inspections, and trial design.
-
Leading With Purpose: Meg Hooton's Global Journey in Biotech1/14/2026
Biotech leadership requires vision, adaptability, and purpose. Aligning values with strategy and fostering collaboration empowers teams and drives innovation in a rapidly evolving industry.
-
Tracking Functional Capacity To Advance Neuromuscular Disease Research2/6/2026
This presentation introduces a dual-endpoint approach to monitoring neuromuscular disease progression through two high-centile digital measures.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1054148730-clinical-outsourcing-partner-FSP]( "What Does 'Powered By Block Clinical' Mean?")
Join us in supporting every part of the clinical trial ecosystem — patients, caregivers, sites, and suppliers — to ensure trials run safely, efficiently, and successfully.
-
![GettyImages-489341888 nurse clinical docs]( "Protocol-Driven, Customized Site Solution Strategy")
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
![GettyImages-1254825733 data]( "Simulants: Unlock Insights And Accelerate Medical Breakthroughs")
Get an overview of this groundbreaking synthetic data product – uniquely derived from Medidata’s exclusive repository of global, standardized historical clinical trial data.
-
![GettyImages-1489414892 Technological Software Engineering Department Manager Using A Laptop]( "Judi Core: Pre-Configured Solutions")
Eliminate manual friction and improve trial visibility with pre-configured, validated workflows. Standardize execution and ensure audit-ready data protection across every global site.
-
![Science technology, Research and Development, Drug discovery-GettyImages-1209661917]( "Purposed-Built For ADC Development")
Bispecific ADCs are reshaping cancer care. Early-phase development is critical, requiring agile CRO support, scientific depth, and real-time data to guide biotech sponsors toward long-term success.
